To any health care institution or headhunter seeking world-class physicians and surgeons, the Quebec legistlature has passed a new special law severly impacting the civil and professional liberties of medical practitioners in our province, where average remuneration was already one of the lowest in North America, in a jursidiction with one of the highest tax rates in the world. You now have the opportunity to recruit top medical talent to your institution! Quebec medical professionals are accustomed to working in a resource limited setting, in high-volume practices for discounted rates. Now's your chance to recruit and you can thank @cdube_sante, @francoislegault and the @coalitionavenir for this health care fire sale!
Prof. @isabellemahe1 presents API-CAT at #ACC2025, published in @NEJM Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose for preventing recurrent VTE, with less clinically relevant bleeding 🩸in patients with cancer.
https://t.co/vmDS2Ap7Uk
🚨 New study alert published in @JACCJournals CI ! 🚨
Can superficial upper extremity venous access replace femoral access in ultrasound-assisted thrombolysis (USAT) for #PE ?
✅ 94% success
✅ Fewer complications
🔗 Read more: https://t.co/WZTEqDIQ6W
🙏@DocHirsch et al.
Join our webinar on VTE and pregnancy! Management of SVT in pregnancy and perspectives 1 year post HIGHLOW study to be discussed (and more)!
@LEOPharmaCA@ThrombosisCan@canvector
Donald Trump faced blowback this week from his GOP presidential rivals over his recent comments on abortion, in which he called Florida’s six-week abortion ban a “terrible mistake” and said that he’d be willing to work with both parties on the issue https://t.co/MR8XefqamL
Glad to share link to our study showing #DOAC was as safe and effective as #VKA in our patient population with #CTEPH, https://t.co/fYMXAvQzhq
Thanks to authors @SusanRKahn1@BenzidiaI , Dr. D. Langleben, Dr JF Morin, Dr. A Abualsaud, Dr. C Robitaille, L. Lesenko and L. MacDonald
Important to have more data on the safety of #DOACs in #CTEPH
N=205
VTE rate 1.10 %/person-year on VKA and 0.32 %/person-year ON DOAC (P = 0.21).
Total bleeding on VKA (2.52 %/person-year) and DOAC (2.52 %/person-year).
https://t.co/aefrqwKYT0
@DocHirsch